We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

35 hedge funds and large institutions have $490M invested in Myovant Sciences Ltd. in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 3

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

43% more capital invested

Capital invested by funds: $342M → $490M (+$148M)

13% more funds holding

Funds holding: 31 → 35 (+4)

Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.8%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
9
Increased
15
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$31.7M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$16.6M
3
RCM
RA Capital Management
Massachusetts
+$14.1M
4
EAM
Eventide Asset Management
Massachusetts
+$11.6M
5
Millennium Management
Millennium Management
New York
+$4.73M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$11.8M
2
JP Morgan Chase
JP Morgan Chase
New York
-$726K
3
Renaissance Technologies
Renaissance Technologies
New York
-$297K
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$40K
5
Bank of America
Bank of America
North Carolina
-$34.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
26
Atria Investments
North Carolina
$201K +$172K +7,581 New
OTC
27
Opera Trading Capital
France
$117K +$100K +4,417 New
PCM
28
Prelude Capital Management
New York
$101K +$86.4K +3,818 New
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$66K +$56.6K +2,500 New
UBS Group
30
UBS Group
Switzerland
$34K +$29.2K +1,292 New
SBL
31
Sargent Bickham Lagudis
Colorado
$6K – – –
Macquarie Group
32
Macquarie Group
Australia
$5K +$4.53K +200 New
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$2.65K – – –
Bank of America
34
Bank of America
North Carolina
$2K -$34.3K -1,515 -94%
Renaissance Technologies
35
Renaissance Technologies
New York
– -$297K -13,000 Closed
PNC Financial Services Group
36
PNC Financial Services Group
Pennsylvania
– -$40K -1,750 Closed
Deutsche Bank
37
Deutsche Bank
Germany
– -$30K -1,306 Closed
TRCT
38
Tower Research Capital (TRC)
New York
– -$5K -200 Closed
ML
39
McAdam LLC
Pennsylvania
– -$1K -35 Closed
Citigroup
40
Citigroup
New York
– +$339 +15 New
1
2

MYOV Hedge Fund Activity: Q3 2018 in Review

35 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q3 2018, worth a combined $490M — up 43% from $342M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MYOV positions and 5 closed out — a net gain of 4 holders — while 15 added to existing stakes and 3 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $31.7M. The largest seller was BlackRock, cutting an estimated $11.8M.

  • 35 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q3 2018, up from 31 in Q2 2018.
  • Funds reported $490M of Myovant Sciences Ltd. stock for Q3 2018, up 43% quarter-over-quarter.
  • 9 funds opened new Myovant Sciences Ltd. positions in Q3 2018 and 5 closed out, a net change of +4 holders.
  • The largest Myovant Sciences Ltd. buyer in Q3 2018 was Janus Henderson Group, an estimated $31.7M added.
  • The largest Myovant Sciences Ltd. seller in Q3 2018 was BlackRock, an estimated $11.8M sold.

Based on aggregated 13F filings for Q3 2018.